Aimedis Token Sale (2021): Sale History, Figure & Outcome

Aimedis conducted a token sale in 2021 for its health-focused blockchain project. The sale raised USD 1.3 million according to available records.

Token Aimedis (AIMx)
Sale year 2021
Category health & medicine
Sale date (per listing) Nov 26, 2021
Documented figure $1,300,000
Outcome unknown
Data tier 3 — aggregator-listed

BMIC presale — live right now: $0.0528542 per token · $646,191 raised · 1,358 buys. Check the live BMIC presale →

Figure per listing — aggregator listings may include private rounds.

What the record shows

The project's AIMx token sale reportedly gathered USD 1.3 million, with documentation noting this amount may include private funding rounds. The record does not provide information about the project's subsequent development or current status.

Era context: the ido era (2021–2023)

This sale occurred during a period when decentralized platforms enabled numerous small token offerings, particularly in specialized sectors like healthcare technology. Many projects from this era lack clear documentation of their long-term outcomes.

This sale is one of the 787 entries in our The IDO Era (2021–2023) era archive, part of the complete history of crypto presales — a sourced dataset where every figure links to the page that shows it.

See a token sale you can verify on-chain →

See today's BMIC presale price →

More from this era

Researching sales running right now? See the regularly updated crypto presale list.

Compare it to a live presale → Put $500 into BMIC now →

Sources

This page is historical research built from a sourced dataset — not a recommendation to buy anything. Token sales are high-risk. Money figures appear only where the cited source shows one. Corrections with sources: support@bmic.ai.

One more look at the live BMIC presale →